Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 1
2013 2
2014 4
2015 2
2016 2
2017 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

10 results

Results by year

Filters applied: . Clear all
Page 1
Recommendations from the Investigational New Drug/Investigational Device Exemption Task Force of the clInical and Translational Science Award Consortium: developing and implementing a sponsor-investigators training program.
Holbein ME, Berglund JP, O'Reilly EK, Hartman K, Speicher LA, Adamo JE, O'Riordan G, Brown JS, Schuff KG; Investigational New Drug/Investigational Device Exemption Task Force of the Clinical and Translational Science Award Consortium. Holbein ME, et al. Among authors: berglund jp. J Investig Med. 2014 Jun;62(5):797-803. doi: 10.2310/JIM.0000000000000083. J Investig Med. 2014. PMID: 24831858 Free PMC article. Review.
ClinicalTrials.gov reporting: strategies for success at an academic health center.
O'Reilly EK, Hassell NJ, Snyder DC, Natoli S, Liu I, Rimmler J, Amspacher V, Burnett BK, Parrish AB, Berglund JP, Stacy M. O'Reilly EK, et al. Among authors: berglund jp. Clin Transl Sci. 2015 Feb;8(1):48-51. doi: 10.1111/cts.12235. Epub 2014 Nov 12. Clin Transl Sci. 2015. PMID: 25387802 Free PMC article.
Early oral immunotherapy in peanut-allergic preschool children is safe and highly effective.
Vickery BP, Berglund JP, Burk CM, Fine JP, Kim EH, Kim JI, Keet CA, Kulis M, Orgel KG, Guo R, Steele PH, Virkud YV, Ye P, Wright BL, Wood RA, Burks AW. Vickery BP, et al. Among authors: berglund jp. J Allergy Clin Immunol. 2017 Jan;139(1):173-181.e8. doi: 10.1016/j.jaci.2016.05.027. Epub 2016 Aug 10. J Allergy Clin Immunol. 2017. PMID: 27522159 Free PMC article. Clinical Trial.
Preparation and Analysis of Peanut Flour Used in Oral Immunotherapy Clinical Trials.
Berglund JP, Szczepanski N, Penumarti A, Beavers A, Kesselring J, Orgel K, Burnett B, Burks AW, Kulis M. Berglund JP, et al. J Allergy Clin Immunol Pract. 2017 Jul-Aug;5(4):1098-1104. doi: 10.1016/j.jaip.2016.11.034. Epub 2017 Jan 26. J Allergy Clin Immunol Pract. 2017. PMID: 28132800 Free PMC article.
Sustained unresponsiveness to peanut in subjects who have completed peanut oral immunotherapy.
Vickery BP, Scurlock AM, Kulis M, Steele PH, Kamilaris J, Berglund JP, Burk C, Hiegel A, Carlisle S, Christie L, Perry TT, Pesek RD, Sheikh S, Virkud Y, Smith PB, Shamji MH, Durham SR, Jones SM, Burks AW. Vickery BP, et al. Among authors: berglund jp. J Allergy Clin Immunol. 2014 Feb;133(2):468-75. doi: 10.1016/j.jaci.2013.11.007. Epub 2013 Dec 19. J Allergy Clin Immunol. 2014. PMID: 24361082 Free PMC article. Clinical Trial.
Peanut oral immunotherapy results in increased antigen-induced regulatory T-cell function and hypomethylation of forkhead box protein 3 (FOXP3).
Syed A, Garcia MA, Lyu SC, Bucayu R, Kohli A, Ishida S, Berglund JP, Tsai M, Maecker H, O'Riordan G, Galli SJ, Nadeau KC. Syed A, et al. Among authors: berglund jp. J Allergy Clin Immunol. 2014 Feb;133(2):500-10. doi: 10.1016/j.jaci.2013.12.1037. J Allergy Clin Immunol. 2014. PMID: 24636474 Free PMC article. Clinical Trial.